DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas (Q34645950)

3 August 2017

title

DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas (English)

1 reference

3 August 2017

1 reference

11

Andreas von Deimling

0 references

Guido Reifenberger

10

object named as

Guido Reifenberger

1 reference

3 August 2017

2

Marietta Wolter

1 reference

3 August 2017

4

Jörg Felsberg

1 reference

3 August 2017

9

Peter Lichter

1 reference

3 August 2017

Annegret Kunitz

1

1 reference

3 August 2017

Jörg van den Boom

3

1 reference

3 August 2017

Björn Tews

5

1 reference

3 August 2017

Meinhard Hahn

6

1 reference

3 August 2017

Axel Benner

7

1 reference

3 August 2017

Michael Sabel

8

1 reference

3 August 2017

Christian Hartmann

12

1 reference

3 August 2017

language of work or name

1 reference

4 July 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

17

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

363-370

1 reference

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

No preferential loss of paternal 19q alleles in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Molecular genetic analysis of oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Pathology and molecular genetics of oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Primary and secondary glioblastomas: from concept to clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Epigenetic silencing of PEG3 gene expression in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Loss of heterozygosity on chromosome 19 in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

A modified and improved method for bisulphite based cytosine methylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Pathology and molecular genetics of astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Parental 19q loss and PEG3 expression in oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Distinct transcription profiles of primary and secondary glioblastoma subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Deletion mapping of chromosome 19 in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00083.X

10.1111/J.1750-3639.2007.00083.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference